Aguilo, Letecia .
HRN: 26-42-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2025
CLINDAMYCIN 300MG (CAP)
01/11/2025
01/17/2025
PO
300mg
Bid
Endometrial Biopsy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes